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ABSTRACT 
In the present study to mask the unpleasant taste of chloroquine phosphate, hot melt coating technique was used as a taste masking tool. Hot 
melt coating is a solvent free technology grants rapid, additionally economical coating process with reduced risk of dissolving drug during 
process and provide uniform application rate of coating agent. Precirol ATO 5 was used as hot melt coating material for taste masking. Tablets 
were prepared by wet granulation method and coated using hot melt coating technique. Coated tablets exhibited good uniformity of drug 
content. Amount of drug release from all batches were evaluated. Taste evaluation of hot melt coated tablets was done by using electronic 
tongue.PrecirolATO5 was found to be a better taste masking agent when used by hot melt coating technique. 
Keywords: Precirol ATO 5, Hot melt coating, taste masking. 
 
Article Info: Received 10 June 2019;     Review Completed 26 July 2019;     Accepted 03 Aug 2019;     Available online 18 August 2019 
Cite this article as: 
Madgulkar AR, Bhalekar MR, Vaidya AD, Kaushal P, Mudalwadkar RP, Development of Hot Melt Coating Technique for 
Taste Masking of Chloroquine Phosphate Tablets, Journal of Drug Delivery and Therapeutics. 2019; 9(4-s):562-568     
http://dx.doi.org/10.22270/jddt.v9i4-s.3213                                                              
*Address for Correspondence:  
Dr. Ashwini R. Madgulkar, AISSMS College of pharmacy, Kennedy Road, Near R.T.O, pune -411001, Maharashtra, India 
 
 
INTRODUCTION  
Coating is one of the effective techniquefor taste masking of 
solid dosage forms.Traditionally sugar coating and various 
polymers were used to this end.Having  some disadvantages  
i.e. it require longer  processing time, use of organic 
solvents,and when aqueous solvent used there is a risk 
ofbacteriological contamination and toxicity as compared to 
Hot Melt Coating. 
An innovative approach, hot melt coating has been reported 
in order to mask the poor taste of many API’s. In HMC 
technique, the coating material is applied on the substrate, in 
a molten state, and no solvent is needed[1], it can reduce 
coating time (no need for drying/evaporation step), 
production costs, safety measurements, solvent  recovery 
and disposal processes [2]. 
HMC is carried out to coat capsules, granules, 
pellets,spherules and tablets. The coatings, which contain a 
lipid and an emulsifier, which facilitate the production of 
coated immediate-release products with a neutral taste [3,4], 
production of sustained release tablets , pellets , used in 
controlling the stability and release properties  of the dosage 
form , used for enteric coating , preparation of orally 
disintegrating tasted masked granules, and tablets . 
Taste, odour and texture form important consideration in 
development of oral dosage forms, they ensure better patient 
compliance and good product quality. Taste masking of bitter 
drugs has achieved the importance as the most of the drugs 
are administered orally[5].Various methods are used for 
taste masking of unpleasant drugs that include flavour’s and 
sweeteners[6,7],inhibiting bitterness [8,9], numing of taste 
buds [10,11],  prodrug, formation of different salts [12,13], 
complexation approaches, microencapsulation ,multiple 
emulsion[14], using viscosity modifiers [15],vehicles and 
liposomes coating of drug particle[16] thereby, minimizing 
the interaction between drug and the taste bud . 
The objective of this study is to evaluate effectivenessof hot 
Melt coating technique as an approach of taste masking by 
coating. Precirol ATO 5 was used as a HMC material for taste 
masking of chloroquinephosphate tablets. The bitterness 
masking of tablets were evaluated using electronic tongue 
and tablets were found to have taste protected. 
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MATERIALS AND METHODS: 
The materials used for the preparation of tablets 
were:Chloroquine   phosphate (Zim laboratories 
Kalmeshwar, Nagpur), lactose monohydrate (Loba chemicals, 
Mumbai),  polyvinylpyrrolidone (Analab fine chemicals, 
Mumbai), Cross povidone (AnalabFine Chemicals, Mumbai), 
colloidal silicon dioxide (Evonik), Magnesium stearate (Loba 
chemicals, Mumbai). 
Precirol ATO 5 was received as a gift sample from 
(Gattefosse,Mumbai),calcium carbonate from 
(Lobachemicals ,Mumbai), PEG 4000 
(Lobachemicals,Mumbai)were procured locally. 
Analytical method: 
Analytical method for estimation of Chloroquine 
phosphate by UV-Visible Spectrophotometry: 
Solution of chloroquine phosphate 1mg/ml was suitably 
diluted to produce solutions in concentration range of 5-30 
µg/ml, the absorbance was noted at wavelength of 342 nm. 
Preparation of uncoated chloroquine phosphate tablets 
(500mg): 
Chloroquine phosphate tablets were prepared by wet 
granulation method, using polyvinyl pyrrolidone in ethanol 
(2 %) as binder. Wet granulation method was applied for 
preparation of chloroquine phosphate tablets. The wet mass 
was screened through 14 mesh, the granules were dried to 
constant weight hot air oven at 60 ℃ temperature. Then, the 
dried granules were passed through 18 mesh and mixed with 
magnesium stearate, colloidal silicon di-oxide and cross 
povidone were added. The resultant mix was evaluated for 
bulk density, angle of repose and Carr’s index and finally 
compressed using 10 mm concave punches (B 
tooling).composition of chloroquine phosphate tablets was 
given in Table1. 
Table 1.Composition of uncoated chloroquine phosphate 
tablets (500mg ). 
Sr.no Ingredients Quantity 
1. Chloroquine phosphate 300mg 
2. Lactose monohydrate 169mg 
3. Polyvinyl pyrollidone 5 mg 
4. Cross povidone 20mg 
5. Colloidal silicon –dioxide 1 mg 
6. Mg stearate 5mg 
 
Coating formula optimization for Hot Melt Coating:The 
quantity of the coating ingredients were decided after initial 
trials. The general formula for coating composition was 
arrived at as given in Table 3. 
Table 3 .General formula for Hot melt coating 
composition 
Sr.no Ingredients Quantity (gm.) 
1. Precirol ATO5 6-8 
2. PEG 4000 3 
3. Calcium carbonate 1-3 
 
Procedure for Coating of chloroquine phosphate tablets 
by Hot Melt Coating Technique in a coating pan: 
HMC was done by using conventional pan coater with slight 
modification of spraytechnique. 
The process was done by first melting the coating agent, and 
raising the inlet temperature slightly above its melting point. 
Substrates were then rolled in the coating pan which was 
heated to a pan temperature of 60℃. The molten coating 
mass was then filled in spray gun and spraying was done 
with controlled rate. After the completion of application of 
coating solution, the substrates were allowed to roll for 
further 10 minutes during which the pan temperature was 
allowed to gradually come down. The substrates were then 
removed, cured for 5-10 minutes. Process parameters were 
given in Table 2. 
Table 2. Process parameters for Hot Melt coating of 
tablets 
Process parameters Settings 
1.Coating time 30 min 
2. Pan speed 23 rpm 
3.Amount of coating solution 10 gm. 
4. Tablet Bed temperature 60- 70℃ 
5. Relative humidity 30-50℃ 
6. Atomizing air pressure 0-15 psi. 
 
Experimental design: 
A 32 factorial design, was used to optimize the quantities of 
precirol ATO 5 (wax)and calcium carbonate (release agent) 
for achieving coating level 10% w/w without adversely 
affecting the drug release. The factors and levels are given in 
the Table 4. 
Table 4.Factors  and Levels of DOE 
DOE Factors  and levels 
Materials 
1.Precirol 
+1 0 -1 
6gm 7gm 8gm 
2. Calcium carbonate 3gm 2gm 1gm 
 
Responses Goal 
Coating level Maximize 
Dissolution (%) Maximize 
 
Coating level: 
Coating level is generally defined as actual percentage weight 
gain relative to the theoretical 100 %weight gain of coating 
of tablets would mean no loss in coating. 
Coating level = (% Wga / % Wgt ) × 100% 
Where, Wgt is the theoretical % weight gain and Wga is the 
actual % weight gain. 
Coating level was determined by following equation: 
 % weight gain = [(Wta –Wtb) × Wtb ] × 100% 
Where , Wta and Wtb are the total batches weight before and 
after coating , respectively . 
Coating level of F1-F9 batch was given in Table 5). 
Evaluation parameters of tablets: 
The uncoated tablets and coated tablets were evaluated for 
hardness, friability, uniformity of weight, disintegration and 
dissolution as per methods described in literature.[19,20]. 
Drug content estimation: five tablets were weighed and 
powdered in a dry morter. Powder equivalent to 500 mg of 
chloroquine phosphate was added and mixed thoroughly; the 
contents of the flask were heated while mixing on a hot 
water bath to dissolve drug .The solution was made up to 
volume with 0.1 N HCl and assayed choroquine  present in 
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each test of tablet and  was calculated using calibration 
curve. 
In-vitro Dissolution studies:  
In vitro dissolution testing was conducted to investigate the 
release rate of chloroquine phosphate hot melt coated tablets 
in comparison with marketed tablets in 900 mL of 0.1N HCl  
for 45 minutes.  The temperature of the dissolution medium 
and the rate of agitation were maintained at 37± 0.50 ℃and 
100 rpm respectively. And 10 ml of dissolution medium was 
withdrawn at specific time interval and the volume replaced 
by fresh dissolution medium, pre warmed to 37± 0.50℃. The 
amount of drug dissolved was determined 
spectrophotometrically using UV spectrophotometer 
Surface roughness: 
Surface roughness was measured visually and was graded 1 -
10 from better to best.  
Scanning electron microscopy: Scanning electron 
microscopy of a coated tablet surface was taken, tablet 
surface was kept on double adhesive tape which kept on a 
stub, latter stub containing sample was placed in scanning 
electron microscope chamber. The scanning electron photo 
microgram was taken at accelerate voltage of 30KV, chamber 
pressure of 0.7 Torr at 500x and 1.00kxmagnifications. Make 
– carl Zeiss and Model No: Supra 5. 
Evaluation of taste masking by using electronic tongue: 
The electronic tongue developed by Analytical 
instrumentation laboratory, Pune. Provided valuable 
information about the evaluation of bitterness intensity as 
function of time.The instrument consisted of working 
electrode, reference electrode and auxiliary electrode.  
RESULT AND DISCUSSION: 
Calibration curve of chloroquine phosphate drug: 
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Fig 1. Calibration curve of chloroquine phosphate in 
distilledwater . 
The standard calibration curve of chloroquine phosphate 
was established at 342 nm and the Beers law was found to be 
obeyed in concentration range of 5 -30 µg/ml as indicated by 
R2 (0.9946) fig.1. 
The equation line was found to be: y = 0.0301x +0.0031. 
Preparation of uncoated chloroquinephosphate tablets: 
Chloroquine has bulk density 0.43gm/ml and angle of repose 
31.020hence wet granulation was done to improve 
compression and flow properties .The precompression 
characteristics of prepared granules were bulk density 0.54 
gm/ml, Carr’s index 11.84%, and angle of repose 26o show 
that the granules exhibited improvement in compression as 
well as flow properties.  
The average weight of tablets was 0.537 gm. and all the 
tablets were within ±5% of it.Thus, the batches 
complieduniformity of weight test. Also the hardness of 
tablets was in acceptable range 259.6-280.1 Newton, the 
friability was  0.119  % and a disintegration time was noted 
at 5 min 30 sec. hence core tablets was prepared for coating . 
 Coating formula optimization for hot melt coating: 
For taste masking by HMC technique, precirol ATO 5 was 
selected, it is partial glyceride used as coating agent for taste 
masking, modified release of the dosage form. It has  M.P.50-
60℃, insoluble in water, and one of the effective solvent free 
alternative for Hot Melt Coating technique .The viscosity of 
molten precirol  ATO 5 estimated at 65 ℃ at 34.3mPas 
obtained at shear rate 94.8 S-1, which make it good partial 
glyceride for Hot Melt Coating.[18]. PEG 4000 which was used 
as a polymer, added in pharmaceutical coating formulations 
as plasticizer to reduce brittleness and increase the flexibility 
of the resulting film, and it play an important role for the 
weight gain of dosage form..[17] 
Procedure for Coating of chloroquine phosphate tablets 
by hot melt coating Technique in a coating pan: 
Waxes and excipients (i.e precirol ATO 5, PEG4000, Calcium 
carbonate) were melted in a separate container. Then, raised 
the temperature of molten mass slightly above the M.P. of 
coating agent. Preweighed the tablets (13.0294gm.) and then 
was rolled in the coating pan which was heated until the pan 
temperature of 60℃ was attained.The molten wax sprayed 
over the tumbling tablet in a small installment with a 
constant rotation of pan(23rpm). Spraying was done 
withspary nozzle at controlled rate. After the completion of 
application of coating solution, the substrates were allowed 
to roll further for 10 minutes during which the temperature 
was allowed to gradually come down. The substrates were 
then removed and cured for 5-10 minutes.The coating level 
was determined by frequently taking weights of coated 
tablets to achieve desired coating level.  
Experimental Design: A 32 design which revealed the effect 
of process materials on the responses as well as any 
interaction within was selected,Table 5).
Table5) : Experimental run and responses for optimization of wax coating formula using 32 factorial design . 
Sr.No Precirol ATO 5(gm) Calcium 
Carbonate(gm) 
Coating level (%) Drug Release (%) 
F1 7 2 9.97 94 
F2 6 2 9.8 93 
F3 6 3 10.3 95 
F4 8 2 10.13 91 
F5 8 3 10.75 85 
F6 8 1 10.44 89 
F7 6 1 10.11 85 
F8 7 1 10.47 83 
F9 7 3 10.62 95 
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Optimization of Precirol ATO 5 (coating polymer) and 
Calcium carbonate  (release compound) : For taste 
masking of tablets,taste masking layer prepared by 
conventional Hot Melt Coating Process,in which  coating 
composition consist of a wax and one of the release agent.If 
the concentration of precirol ATO 5 increases,so there is 
increase in coating level and eventually percentage of drug 
releasedecreases.The increase in quantity of release 
agentincreases coating level and drug release.The factorial 
designs are very good tool to optimize quantities of 
formulation ingredients to achieve desired performance 
characteristics to the formulation. It also reveals the 
interactions within the two factors. 
By using 32 factorial design nine batches of hot melt coated 
tablets were prepared,varying two independent variables 
Precirol ATO 5 and calcium carbonate. The cumulative % 
drug release at 45 minutes and coating level (%) were taken 
as dependent variables were determined. 
The coating level was seen to be affected more significantly 
by calcium carbonate. Equation (1). However at higher levels 
of calcium carbonate the coating level declined which may be 
due to non-adhesion of added calcium carbonate. The 
precirol however had similar effects in high or low levels of 
calcium carbonate. fig.2) 
The drug release increases with increasing concentration of 
Calcium carbonate,it can be observed from 3D plot fig.3), that 
drug release is dependent more on releasing agent and 
precirol had a very insignificant effect.Equation(2). 
Equation for coating level: 
Coating level = +10.03+0.1850*A+0.1083*B+0.0300*AB-
0.0938*A2+0.4817 *B2………..(1) 
Equation for % of drug release: 
% of drug release = +93.44+0.3333*A+5.50*B- 0.2500*AB-
0.6667*A2-3.17*B2……...(2) 
Using desirability function the numerical optimization was 
done and concentration for optimized batch selected 
was,7gm of precirol ATO 5 and 2gm of calcium carbonate   
(desirability=1.000).The optimized batch was prepared and 
evaluated which showed very less difference between 
predicted and observed values. Percentage predicted error of 
coating level was 0.9775% and drug release was 0.6847%. 
Thus prognostic ability of the model was established.  
The formulations prepared as per the experimental design 
were evaluated and the analysis of experimental results was 
done by using Stat-Ease Design Expert. The ANOVA, P-value 
and Model F-value for coating level and drug release were 
obtained .Table 6. 
 
Table 6: ANOVA RESULTS OF SELECTED MODELS: 
Sr. No. Outcomes Coating level   % of drug release  
1. Models Quadratic Quadratic 
2. Sum of squares 0.7627 203.36 
3. Df 5 5 
4. Mean square   0.1525 40.67 
5. R2    VALUE 0.9829 0.9829 
6. F – VALUE 34.55 34.59 
7. P – VALUE 0.0075 0.0074 
8. ADEQUATE PRECISION 18.2484 13.8354 
 
The Model F-value of all models  implies the both models 
were significant. In coating levelthe Model, F-value of 34.55 
implies the model is significant, there is only a 0.75% chance 
that an F-value this large could occur due to noise. In drug 
release Model,there is 0.74 %chance that an F- value this 
large could occur due to noise. P-values less than 0.0500 
indicate both model terms are significant. If Values greater 
than 0.1000 indicate the model terms are not significant. 
Higher R2 value indicated good agreement between 
formulation variables and response parameters. Adequate 
Precision measures the signal to noise ratio. A ratio greater 
than 4 is desirable. Ratios of a coating level and % drug 
release indicate an adequate signal. Thus, models can be 
used to predict the values of the response parameters at 
selected values of formulation variables within the design 
space.
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Fig .2) Response surface plot showing influence of Precirol ATO 5 and Calcium carbonate on a coating level of tablet. 
 
Fig 3) Response surface plot showing influence of precirol ATO5 and CaCo3 on of drug release. 
 
Evaluation of coated tablets with optimized 
parameters: 
The average weight of tablets was 0.575gmandall the 
tablets were within ±5% of it, thus the batches complied 
uniformity of weight test. Also the hardness of tablets was 
in acceptable range 269.2- 280.1 Newton, the friability 
was0.191 % and a disintegration time was noted at 28min.  
Drug content estimation: The drug content uniformity of 
optimization batch was found to be the value ranged from 
96.9 ±0.76 to 98.6±0.94, which was within acceptable limit. 
In-vitro dissolution studies: Results of the dissolution 
studies of the hot melt coated tablet   batches (F1-F9) 
which are given in the fig 4) .dissolution studies of all 
batches were done. So it was found that F1 is a optimized 
batch. F1 batch shows more drug release as compared to 
marketed tablets.  
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Fig.4) Cumulative percentage drug release of F1-F9 
batches. 
Scanning electron microscopy: 
The surface morphology of chloroquine phosphate wax 
coated tablet was studied by SEM. The morphology of 
tablets was observed uniform as shown in fig.5) and fig .6). 
 
Fig.5) SEM Images at 500X magnification of precirol 
ATO 5 (wax) coated tablet surface. 
 
Fig.6) SEM Images at 500X magnificationof precirol 
ATO 5 (wax) coated tablet surface. 
Evaluation of taste masking by using electronic tongue: 
The e-Tongue distinguishes tastes based on specific 
interactions like hydrogen bonds and vander Waal’s 
interactions between samples at membrane interface 
which are detected by electrodes and converted into 
electrical signals. PCA compresses voltage into two 
principal components (PCA1 and PCA 2) which accounts 
for maximum variance and minimum correlation within 
data .Three solutions were prepared 2 mM, 8mM and 
20mM ,i.e low,Medium and at  High concentrations. at each 
concentration drug show bitterness. and specifically at a 
very low concentration drug also shows bitterness,so it 
means that  chloroquine phosphate bitter in nature. and 
threshold bitterness concentration was found at 2mM 
concentration.  
PCA analysis was performed on acquired data. it 
compresses the acquired data point in two principal 
component which has maximum variance and minimum 
co-relation with acquired data. The principal components 
were plotted. More the distance between PCA values, more 
is the difference in their bitterness intensity so as shown in 
fig.7) concluded that, as the concentration of drug 
increases its bitterness intensity also increases.  PCA graph 
of waxcoating formulation was shown in fig8).Initially 
bitterness has not seen at 20sec,it was seen at 40 sec and 
60sec 40 sec is near to bitter threshold of 2mM.So 
bitterness was seen at 40 sec, so we can put tablet on 
mouth upto 40 sec. 
 
Fig.7) PCA graph of Drug (chloroquine phosphate) in comparison with bitter standard (quinine). 
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Fig.8) PCA graph of wax coated formulation. 
 
CONCLUSION 
From the present study it was concluded that, coating agent 
precirol ATO5 is efficient in masking of bitter taste of drug 
by Hot melt coating. The coating level of 10% W/W is 
require to mask complete bitter taste of drug as indicated 
by study.Thus, hot melt coating is effective, less time 
consuming,ecofriendly for taste masking applications of 
solid oral dosage formand it was seen that dissolution rate  
of  wax coated tablets was more  as compared to marketed 
tablets .  
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